Tegelased 3

Therapeutic bedside monitoring of beta-lactam antibiotics in neonates with suspected or proven late onset sepsis: observational study

  • Observational study in neonates and infants, Infants with chronological age < 90 days old with confirmed or suspected sepsis requiring treatment with study antibiotics (piperacillin/tazobactam, ceftazidime, cefepime or meropenem) will be included. 
  • Study objective is to assess the ability to perform real-time monitoring of beta-lactam antibioticswith the MON4STRAT device in neonates and infants.

Funding: European Commission, under the FP7 programme

EUDRA-CT: 2018-000450-21

Link: www.mon4strat.ulg.ac.be


Project's status:

Tegelased 3